Oppenheimer Initiates Odyssey Therapeutics at Outperform With $40 Price Target

Cantor Fitzgerald Initiates Odyssey Therapeutics at Overweight

Truist Downgrades Taylor Morrison Home to Hold From Buy Following Deal Announcement, Keeps $72.50 Price Target

Taylor Morrison Home (TMHC) has an average rating of hold and mean price target of $70, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Choice Equity Downgrades Concord Biotech to Reduce from Add; Price Target is INR1,045